No definition available.
Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)
C3_MENINGES_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
130 |
4. Check minimum number of eventsNone |
130 |
5. Include endpointsNone |
130 |
6. Filter based on genotype QC (FinnGen only) |
130 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 130 | 82 | 48 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 60.73 | 57.70 | 65.91 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
25
45
6.64
13.98
4.2
4.7
24.5
25.3
mmol/l
0.40
25
45
14
5
31.06
10.97
2.9
2.8
—
—
—
0
0
33
95
4.32
10.75
5.8
3.0
—
—
—
0
0
14
21
7.35
9.09
3.6
1.5
—
—
—
0
0
30
111
3.21
6.58
5.2
4.7
1.7
1.9
mmol/l
0.14
24
89
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
27
5.24
6.12
2.3
2.1
0.4
0.5
u/ml
—
6
12
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
52
288
2.34
5.06
3.5
2.9
0.2
0.5
e6/l
1.02
43
204
75
489
2.26
4.91
10.3
4.9
1.2
1.2
mmol/l
0.27
57
427
68
432
2.20
4.68
10.9
4.5
1.2
1.2
mmol/l
0.50
63
387
67
427
2.17
4.53
7.1
3.3
34.3
35.7
g/l
1.46
62
398
38
198
2.30
4.15
7.1
2.1
2.5
2.4
mmol/l
0.81
33
161
57
352
2.10
4.08
3.4
2.9
—
—
—
0
0
15
51
3.19
3.71
4.9
5.7
0.7
0.8
%
0.46
15
51
64
426
1.99
3.62
5.8
3.4
—
—
—
0
0
8
14
6.01
3.39
2.0
1.3
—
—
—
0
0
39
240
1.89
2.64
4.8
4.2
0.0
0.0
estimate
0.00
27
67
6
11
5.66
2.57
2.0
1.2
—
—
—
0
0
34
205
1.89
2.43
3.6
1.9
—
—
—
0
0
8
22
3.80
2.40
1.4
1.4
—
—
—
0
0
12
48
2.65
2.26
8.9
1.6
5.7
2.6
ug/l
0.55
12
35
6
163
0.34
2.21
1.5
1.5
—
—
—
0
0
89
1029
0.57
2.16
4.3
4.6
6.0
6.0
mmol/l
0.07
76
933
47
326
1.69
2.08
2.0
2.0
130.7
219.0
u/l
0.58
47
310
57
418
1.65
2.03
3.4
3.9
16.3
34.8
ng/l
2.76
47
296
8
27
3.09
1.97
1.1
1.3
—
—
—
0
0
14
65
2.29
1.96
1.9
1.6
—
—
—
0
0
6
16
3.88
1.96
2.0
1.2
—
—
—
0
0
6
18
3.44
1.77
2.0
1.2
—
—
—
0
0
85
973
0.63
1.60
5.9
6.2
41.2
40.3
mmol/mol
0.49
76
907
93
1036
0.64
1.41
4.0
5.1
2.7
2.7
mmol/l
0.27
81
952
49
377
1.48
1.31
4.8
3.7
—
—
—
0
0
27
185
1.58
1.21
3.0
2.5
1.3
1.2
e6/l
0.02
14
96
6
26
2.37
1.20
13.0
2.0
8.0
260.9
u/ml
—
6
21
7
30
2.41
1.14
1.6
3.1
—
—
—
0
0
11
60
1.91
1.06
1.5
1.5
—
—
—
0
0
5
22
2.32
1.04
1.8
1.3
—
—
—
0
0
5
22
2.32
1.04
1.8
1.3
—
—
—
0
0
60
497
1.38
1.02
6.1
5.0
0.0
0.0
estimate
0.00
26
68
59
489
1.38
1.00
4.4
3.7
0.0
0.0
estimate
0.00
27
70
92
1006
0.71
0.96
3.5
4.6
1.5
1.5
mmol/l
0.07
79
921
60
504
1.35
0.92
4.3
3.7
0.0
0.0
estimate
0.00
27
66
88
964
0.73
0.86
3.3
4.1
1.3
1.3
mmol/l
0.05
78
876
30
229
1.40
0.81
2.0
1.7
1.2
1.1
mg/l
0.20
23
177
52
435
1.33
0.79
2.5
2.4
78.7
77.4
nmol/l
0.12
43
380
15
217
0.65
0.79
3.8
3.7
28.1
24.3
%
—
9
101
18
128
1.47
0.70
7.5
4.4
0.9
1.0
mmol/l
0.96
18
115
28
219
1.36
0.66
1.6
1.8
437.0
33708312.0
pmol/l
0.50
21
178
23
175
1.38
0.64
3.3
2.8
4.5
2.7
e6/l
0.18
11
88
21
158
1.39
0.62
2.1
1.7
—
—
—
0
0
49
564
0.79
0.61
3.1
3.0
—
—
—
0
0
8
54
1.51
0.58
6.1
4.1
27.9
24.6
mmol/l
—
8
46
95
1011
0.78
0.57
3.6
4.6
4.7
4.6
mmol/l
0.21
84
933
19
143
1.38
0.56
3.5
2.5
12.5
12.8
umol/l
0.04
19
132
9
60
1.54
0.56
1.4
1.6
—
—
—
0
0
6
96
0.61
0.54
1.7
1.8
27.8
28.4
u/l
—
6
77
13
176
0.71
0.50
1.2
1.3
12.5
7.6
u/ml
—
7
60
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
8.6
—
0
8
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
35
1.45
0.39
1.6
1.6
—
—
—
0
0
6
44
1.38
0.35
1.7
1.7
—
—
—
0
0
105
1007
1.22
0.35
28.5
12.7
21.5
23.2
mg/l
0.29
96
772
6
46
1.32
0.33
1.3
1.9
9.8
16.0
nmol/l
—
6
41
14
110
1.31
0.33
1.8
1.7
—
—
—
0
0
14
110
1.31
0.33
1.7
1.7
—
—
—
0
0
92
963
0.85
0.32
5.4
4.7
2.2
1.9
mu/l
1.49
84
875
26
296
0.85
0.27
1.6
1.6
1.4
1.3
mmol/l
0.12
18
253
24
208
1.19
0.26
2.0
1.6
1201.9
1094.0
nmol/l
0.21
15
157
0
11
0.00
0.21
0.0
1.1
—
3.2
—
0
5
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
98
951
1.12
0.18
26.6
11.7
79.0
76.5
ml/min/173m2
0.53
90
770
82
791
1.10
0.16
4.8
3.9
14.8
14.9
pmol/l
0.01
75
721
16
181
0.87
0.15
1.4
1.3
55.0
27.4
iu/ml
—
7
63
13
147
0.87
0.12
1.5
1.4
—
—
—
0
0
26
277
0.92
0.09
1.3
1.6
17.3
22.4
nmol/l
0.85
21
238
6
53
1.14
0.09
3.0
2.2
0.7
1.1
%
—
6
53
6
56
1.07
0.09
1.0
1.1
—
—
—
0
0
6
73
0.81
0.08
1.7
1.9
—
—
—
0
0
8
75
1.07
0.07
1.4
1.7
—
—
—
0
0
44
451
0.96
0.03
2.0
2.0
85.8
97.8
pmol/l
0.83
20
229
35
340
1.04
0.03
2.8
3.1
675.5
1545.2
ng/l
1.95
30
282
77
778
0.97
0.02
4.7
3.9
14.1
12.1
mm/h
0.38
71
711
12
121
0.99
0.00
5.8
6.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
8
83
0.96
0.00
1.4
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_MENINGES_EXALLC – Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).